文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

难治性心脏骤停患者经静脉-动脉体外膜氧合与目标温度管理后延迟肠内喂养与结局的相关性

Outcomes associated with delayed enteral feeding after cardiac arrest treated with veno-arterial extracorporeal membrane oxygenation and targeted temperature management.
PubMed 文献 · Resuscitation · 2021-05-14
一句话结论接受ECPR和TTM的难治性院外心脏骤停患者中,延迟肠内喂养(>48小时)与神经功能良好生存率升高相关(29% vs 54%,校正OR CI 1.04-7.25,p=0.04),喂养相关不良事件无差异。

本研究为回顾性分析,纳入142例因室颤或室速导致院外心脏骤停并接受ECPR和目标温度管理的连续患者,比较入住ICU后<48小时早期肠内喂养与>48小时延迟肠内喂养的神经功能良好生存及临床结局。90/142(63%)患者启动肠内喂养,其中早期34/90(38%),延迟56/90(62%)。在纳入接受营养患者的校正分析中,延迟肠内喂养与神经功能良好生存几率增加相关(29% vs 54%,CI 1.04-7.25,p=0.04)。肺炎(18% vs 27%,p=0.16)、消化道出血(5.9% vs 3.6%,p=0.42)、肠缺血(5.9% vs 5.4%,p=0.90)、肠梗阻(12% vs 11%,p=0.98)及气管切开需求(15% vs 20%,p=0.81)在早期与延迟喂养组间均无显著差异。结论认为在该人群中延迟肠内营养与神经功能良好生存改善相关,喂养相关不良事件与喂养启动时机无关。

要点

  • 在ECPR联合TTM的难治性OHCA患者中,延迟肠内喂养(>48小时)与神经功能良好生存率升高相关(29% vs 54%,校正OR CI 1.04-7.25,p=0.04)。
  • 90/142(63%)患者启动肠内喂养,其中早期(<48小时)34/90(38%),延迟(>48小时)56/90(62%)。
  • 肺炎(18% vs 27%,p=0.16)、消化道出血(5.9% vs 3.6%,p=0.42)、肠缺血(5.9% vs 5.4%,p=0.90)、肠梗阻(12% vs 11%,p=0.98)在早期与延迟喂养组间无显著差异。
  • 气管切开需求在早期与延迟喂养组间无显著差异(15% vs 20%,p=0.81)。

适用人群与场景

  • 因室颤或室速导致院外心脏骤停(OHCA)并接受体外心肺复苏(ECPR)和目标温度管理(TTM)的难治性心脏骤停患者,共142例连续患者。

处置流程与药物剂量

  • 肠内喂养时机分组:早期肠内营养为入住ICU后<48小时启动,延迟肠内营养为入住ICU后>48小时启动。

研究设计与关键结果

  • 研究类型:回顾性分析;样本量:142例连续患者;人群:因室颤或室速导致OHCA并接受ECPR和TTM的难治性心脏骤停患者;干预与对照:早期肠内营养(<48小时,34/90,38%) vs 延迟肠内营养(>48小时,56/90,62%)。
  • 主要终点:在纳入接受营养患者的校正分析中,延迟肠内喂养与神经功能良好生存几率增加相关(29% vs 54%,CI 1.04-7.25,p=0.04)。
  • 关键次要终点:肺炎发生率早期组18% vs 延迟组27%(p=0.16);消化道出血5.9% vs 3.6%(p=0.42);肠缺血5.9% vs 5.4%(p=0.90);肠梗阻12% vs 11%(p=0.98);气管切开需求15% vs 20%(p=0.81),均无显著差异。
  • 肠内喂养启动情况:90/142(63%)患者启动肠内喂养。

证据类型、等级与局限

  • 证据类型:回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在ECPR联合TTM的难治性OHCA患者中,延迟肠内喂养(>48小时)与神经功能良好生存改善相关,且未增加喂养相关不良事件,提示对此类患者延迟启动肠内营养可能获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: While early enteral nutrition is generally preferred in critically ill patients, the optimal timing of feeding among refractory cardiac arrest patients is unknown. We examined the association between timing of enteral nutrition and patient survival and safety outcomes in patients with refractory out-of-hospital cardiac arrest (OHCA) who were treated with extracorporeal cardiopulmonary resuscitation (ECPR).

METHODS: We performed a retrospective analysis of 142 consecutive patients presenting with OHCA due to ventricular fibrillation or ventricular tachycardia treated with ECPR and targeted temperature management (TTM). Neurologically favorable survival and clinical outcomes were compared between patients who received early enteral nutrition (<48 h after admission to the intensive care unit) and patients receiving delayed enteral nutrition (initiated >48 h after admission).

RESULTS: Enteral nutrition was initiated in 90/142 (63%) patients. Early enteral nutrition was provided in 34/90 (38%) while delayed nutrition occurred in 56/90 (62%). In adjusted analysis including patients who received nutrition, delayed enteral feeding was associated with increased odds of neurologically favorable survival (29 vs 54%, CI 1.04-7.25, p = 0.04). There were no significant differences in the incidence of pneumonia (18 vs 27%, p = 0.16), gastrointestinal bleeding (5.9 vs 3.6%, p = 0.42), intestinal ischemia (5.9 vs 5.4%, p = 0.90), ileus (12 vs 11%, p = 0.98), or need for tracheostomy (15 vs 20%, p = 0.81) between early and late feeding groups.

CONCLUSION: In patients with refractory OHCA treated with ECPR and TTM, delayed enteral nutrition was associated with improved neurologically favorable survival. Adverse events related to enteral feeding were not associated with timing of feeding initiation.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Gutierrez A, Carlson C, Kalra R, et al. Outcomes associated with delayed enteral feeding after cardiac arrest treated with veno-arterial extracorporeal membrane oxygenation and targeted temperature management. Resuscitation. 2021. PMID: 33965476. doi:10.1016/j.resuscitation.2021.04.029

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。